Expert Opinion on Drug Discovery,
Journal Year:
2021,
Volume and Issue:
16(10), P. 1163 - 1173
Published: April 30, 2021
Introduction:
Animal
venoms
are
a
complex
mixture
of
bioactive
molecules
that
have
evolved
over
millions
years
for
prey
capture
and
defense
from
predators.
Venom
consists
many
different
types
molecules,
with
disulfide-rich
peptides
being
major
component
in
most
venoms.
The
study
these
potent
highly
selective
has
led
to
the
development
venom-derived
drugs
diseases
such
as
type
2
diabetes
mellitus
chronic
pain.
As
technologies
improved,
more
been
discovered
venomous
animals.
Many
may
applications
tools
understanding
normal
disease
physiology,
therapeutics,
cosmetics
or
agriculture.Areas
covered:
This
article
reviews
approved
by
FDA
currently
development.
It
discusses
challenges
faced
peptide
during
drug
future
peptides.Expert
opinion:
New
techniques
toxin
driven
discovery
expanding
pipeline
peptides.
There
preclinical
clinical
trials
would
remained
undiscovered
using
traditional
approaches.
A
renewed
focus
on
venoms,
advances
technology,
will
broaden
diversity
therapeutics
expand
our
knowledge
their
molecular
targets.
GigaScience,
Journal Year:
2022,
Volume and Issue:
11
Published: Jan. 1, 2022
Abstract
Venoms
have
evolved
>100
times
in
all
major
animal
groups,
and
their
components,
known
as
toxins,
been
fine-tuned
over
millions
of
years
into
highly
effective
biochemical
weapons.
There
are
many
outstanding
questions
on
the
evolution
toxin
arsenals,
such
how
venom
genes
originate,
contributes
to
fitness
venomous
species,
which
modifications
at
genomic,
transcriptomic,
protein
level
drive
evolution.
These
received
particularly
little
attention
outside
snakes,
cone
snails,
spiders,
scorpions.
Venom
compounds
further
become
a
source
inspiration
for
translational
research
using
diverse
bioactivities
various
applications.
We
highlight
here
recent
advances
new
strategies
modern
venomics
discuss
technological
innovations
multi-omic
methods
dramatically
improve
animals.
The
study
genomes
through
CRISPR
knockdown
technologies
will
increase
our
understanding
toxins
evolve
functions
they
different
ontogenetic
stages
during
development
Mass
spectrometry
imaging
combined
with
spatial
transcriptomics,
situ
hybridization
techniques,
computer
tomography
gives
us
insights
distribution
system
function
apparatus.
All
these
evolutionary
biological
contribute
more
efficiently
identify
compounds,
can
then
be
synthesized
or
produced
adapted
expression
systems
test
bioactivity.
Finally,
we
critically
agrochemical,
pharmaceutical,
therapeutic,
diagnostic
(so-called
translational)
aspects
venoms
from
humans
benefit.
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
10
Published: Jan. 17, 2024
Snake
venom
contains
many
toxic
proteins
that
can
destroy
the
circulatory
system
or
nervous
of
prey.
Studies
have
found
these
snake
potential
to
treat
cardiovascular
and
diseases.
Therefore,
study
protein
is
conducive
development
related
drugs.
The
research
technologies
based
on
traditional
biochemistry
accurately
identify
proteins,
but
experimental
cost
high
time
long.
Artificial
intelligence
technology
provides
a
new
means
strategy
for
large-scale
screening
from
perspective
computing.
In
this
paper,
we
developed
sequence-based
computational
method
recognize
toxin
proteins.
Specially,
utilized
three
different
feature
descriptors,
namely
g-gap
,
natural
vector
word
2
vector,
encode
sequences.
analysis
variance
(ANOVA),
gradient-boost
decision
tree
algorithm
(GBDT)
combined
with
incremental
selection
(IFS)
were
used
optimize
features,
then
optimized
features
input
into
deep
learning
model
training.
results
show
our
achieve
prediction
performance
an
accuracy
82.00%
in
10-fold
cross-validation.
further
verified
independent
data,
rate
reaches
81.14%,
which
demonstrated
has
excellent
robustness.
Toxins,
Journal Year:
2024,
Volume and Issue:
16(3), P. 117 - 117
Published: Feb. 29, 2024
Among
the
various
natural
compounds
used
in
alternative
and
Oriental
medicine,
toxins
isolated
from
different
organisms
have
had
their
application
for
many
years,
Apis
mellifera
venom
has
been
studied
most
extensively.
Numerous
studies
dealing
with
positive
assets
of
bee
(BV)
indicated
its
beneficial
properties.
The
usage
products
to
prevent
occurrence
diseases
treatment
is
often
referred
as
apitherapy
based
mainly
on
experience
traditional
system
medical
practice
diverse
ethnic
communities.
Today,
a
large
number
are
focused
antitumor
effects
BV,
which
attributed
basic
polypeptide
melittin
(MEL).
Previous
that
BV
major
constituent
MEL
cause
strong
toxic
effect
cancer
cells,
such
liver,
lung,
bladder,
kidney,
prostate,
breast,
leukemia
while
less
pronounced
was
observed
normal
non-target
cells.
Their
proposed
mechanisms
action,
proliferation
growth
inhibition,
cell
cycle
alterations,
induction
death
through
several
mechanisms,
associated
activation
phospholipase
A2
(PLA2),
caspases,
matrix
metalloproteinases
destroy
cellular
need
be
elucidated
molecular
level,
key
issue
do
trigger
apoptotic
cascade.
Apoptosis
could
either
consequence
plasmatic
membrane
fenestration
or
result
direct
interaction
components
pro-apoptotic
anti-apoptotic
factors.
peptides
enzymes
plasma
crucial
step
whole
process.
However,
before
possible
remedy,
it
identify
correct
route
exposure
dosage
potential
therapeutic
use
well
side
cells
tissues
avoid
any
adverse
event.
Transactions of the Royal Society of Tropical Medicine and Hygiene,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 3, 2025
Abstract
Snake
venom,
a
complex
mixture
of
proteins,
has
attracted
human
attention
for
centuries
due
to
its
associated
mortality,
morbidity
and
other
therapeutic
properties.
In
sub-Saharan
Africa
(SSA),
where
snakebites
pose
significant
health
risk,
understanding
the
genetic
variability
snake
venoms
is
crucial
developing
effective
antivenoms.
The
wide
geographic
distribution
venomous
species
in
SSA
countries
demonstrates
need
develop
specific
broad
However,
development
antivenoms
been
hindered
by
different
factors,
such
as
antivenom
cross-reactivity
polygenic
paratopes.
While
have
numerous
across
region,
current
antivenoms,
SAIMR
polyvalent
Premium
Serums
&
Vaccines,
exhibit
varying
degrees
cross-reactivity.
Such
ability
cross-react
enables
target
multiple
components
from
species.
advent
biotechnological
innovations,
including
recombinant
antibodies,
small-molecule
drugs,
monoclonal
antibodies
synthetic
presents
options
eliminating
limitations
with
traditional
plasma-derived
challenges
still
persist,
especially
SSA,
addressing
variability,
evidenced
inadequate
testing
capacity
limited
genomic
research
facilities.
This
comprehensive
review
explores
emphasizing
venom
composition
various
their
interactions.
information
critical
strategies
during
development.
Finally,
it
offers
concerning
extensive
collaborative
engagements,
technological
advancements
evaluations
produce
targeted
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
34(13)
Published: Nov. 16, 2021
Abstract
Biological
neutralization
represents
a
general
strategy
that
deploys
therapeutic
agents
to
bind
with
harmful
molecules
or
infectious
pathogens,
block
their
bioactivity,
and
thus
prevent
them
from
causing
the
diseases.
Here,
comprehensive
review
of
using
cell‐membrane‐coated
nanoparticles,
namely
“cellular
nanosponges,”
as
host
decoys
for
wide
range
biological
applications
is
provided.
Compared
traditional
strategies,
cellular
nanosponges
stand
out
by
mimicking
susceptible
cells
rather
than
accommodating
structures
causative
design
therapeutics.
As
all
pathological
must
interact
bypass
diversity
these
create
function‐driven
broad‐spectrum
solutions.
The
focuses
on
recent
progress
this
new
nanomedicine
platform
against
five
primary
agents,
including
bacterial
toxins,
chemical
toxicants,
inflammatory
cytokines,
antibodies,
viruses.
Existing
studies
have
established
versatile
tools
neutralization.
A
thorough
nanosponge
technology
expected
inspire
more
refined
designs
unique
address
unsolved
medical
problems.
Pharmacological Research,
Journal Year:
2022,
Volume and Issue:
177, P. 106076 - 106076
Published: Jan. 21, 2022
Drug
discovery
from
natural
sources
is
going
through
a
renaissance,
having
spent
many
decades
in
the
shadow
of
synthetic
molecule
drug
discovery,
despite
fact
that
product-derived
compounds
occupy
much
greater
chemical
space
than
those
created
chemistry
methods.
With
this
new
era
comes
possibilities,
not
least
novel
targets
have
emerged
recent
times
and
development
state-of-the-art
technologies
can
be
applied
to
sources.
Although
progress
has
been
made
with
some
immunomodulating
drugs,
there
remains
pressing
need
for
agents
used
treat
wide
variety
conditions
arise
disruption,
or
over-activation,
immune
system;
products
may
therefore
key
filling
gap.
Recognising
that,
at
present,
no
authoritative
article
details
current
immunomodulatory
activity
products,
in-depth
review
arisen
joint
effort
between
International
Union
Basic
Clinical
Pharmacology
(IUPHAR)
Natural
Products
Immunopharmacology
Sections,
contributions
number
world-leading
researchers
field
product
provide
"position
statement"
on
what
offer
search
argents.
To
end,
we
historical
look
previous
discoveries
naturally
occurring
immunomodulators,
present
picture
status
insight
into
future
opportunities
challenges
drugs
immune-related
diseases.
OncoTargets and Therapy,
Journal Year:
2022,
Volume and Issue:
Volume 15, P. 783 - 797
Published: July 1, 2022
Abstract:
Potassium
(K
+
)
channels
are
highly
regulated
membrane
proteins
that
control
the
potassium
ion
flux
and
respond
to
different
cellular
stimuli.
These
grouped
into
three
major
families,
Kv
(voltage-gated
K
channel),
Kir
(inwardly
rectifying
channel)
K2P
(two-pore
channels),
according
structure,
mediate
currents.
In
cancer,
alterations
in
channel
function
can
promote
acquisition
of
so-called
hallmarks
cancer
–
cell
proliferation,
resistance
apoptosis,
metabolic
changes,
angiogenesis,
migratory
capabilities
emerging
as
targets
for
development
new
therapeutic
drugs.
this
review,
we
focus
our
attention
on
associated
with
most
relevant
prevalent
types.
We
summarize
knowledge
about
structure
function,
their
dysregulated
expression
discuss
modulator
strategies
designing
Keywords:
channels,
blockers,
expression,